Loading...
Benchmark Holdings plc
BHCCF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.37
$0.00(0.00%)
Benchmark Holdings plc (BHCCF) Financial Performance & Income Statement Overview
Review Benchmark Holdings plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-46.68%
↓ 46.68%
Operating Income Growth
-567.78%
↓ 567.78%
Net Income Growth
-70.50%
↓ 70.50%
Operating Cash Flow Growth
-89.98%
↓ 89.98%
Operating Margin
-79.09%
↓ 79.09%
Gross Margin
47.79%
↑ 47.79%
Net Profit Margin
90.60%
↑ 90.60%
ROE
18.62%
↑ 18.62%
ROIC
-12.62%
↓ 12.62%
Benchmark Holdings plc (BHCCF) Income Statement & Financial Overview
Review Benchmark Holdings plc's (BHCCF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $17.72M | -$20.55M | $30.69M | $39.75M |
| Cost of Revenue | $10.15M | -$9.63M | $15.07M | $26.41M |
| Gross Profit | $7.58M | -$10.92M | $15.62M | $13.35M |
| Gross Profit Ratio | $0.43 | $0.53 | $0.51 | $0.34 |
| R&D Expenses | $567000.00 | -$2.02M | $1.41M | $1.54M |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $9.86M |
| Operating Expenses | $13.62M | $14.37M | $22.11M | $11.40M |
| Total Costs & Expenses | $23.77M | $4.74M | $37.18M | $37.81M |
| Interest Income | $18000.00 | $0.00 | $65000.00 | $76000.00 |
| Interest Expense | $2.31M | $0.00 | $2.92M | $2.71M |
| Depreciation & Amortization | $5.95M | $22.37M | $8.42M | $7.54M |
| EBITDA | $916000.00 | -$6.54M | $1.92M | $9.48M |
| EBITDA Ratio | $0.05 | $0.32 | $0.06 | $0.24 |
| Operating Income | -$6.04M | -$25.29M | -$6.50M | $1.94M |
| Operating Income Ratio | -$0.34 | $1.23 | -$0.21 | $0.05 |
| Other Income/Expenses (Net) | -$1.02M | -$3.35M | -$2.92M | -$3.28M |
| Income Before Tax | -$7.07M | -$28.64M | -$9.42M | -$1.34M |
| Income Before Tax Ratio | -$0.40 | $1.39 | -$0.31 | -$0.03 |
| Income Tax Expense | $213000.00 | -$3.08M | $529000.00 | $477000.00 |
| Net Income | -$9.93M | -$20.60M | -$9.91M | -$1.32M |
| Net Income Ratio | -$0.56 | $1.003 | -$0.32 | -$0.03 |
| EPS | -$0.01 | -$0.03 | -$0.01 | -$0.002 |
| Diluted EPS | $0.00 | -$0.03 | -$0.01 | -$0.002 |
| Weighted Avg Shares Outstanding | $739.78M | $739.78M | $739.71M | $739.46M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $739.78M | $739.71M | $739.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan